Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593271 | SCV000704805 | likely pathogenic | not provided | 2016-12-21 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostics Laboratory, |
RCV000761231 | SCV000891187 | likely pathogenic | Adams-Oliver syndrome 1 | 2018-08-14 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003420034 | SCV004113948 | likely pathogenic | DOCK6-related disorder | 2023-02-21 | criteria provided, single submitter | clinical testing | The DOCK6 c.3562C>T variant is predicted to result in premature protein termination (p.Gln1188*). To our knowledge, this variant has not been reported in a patient with a DOCK6 related disorder. This variant is reported in 0.0057% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-11328056-G-A). Nonsense variants in DOCK6 are expected to be pathogenic. This variant is interpreted as likely pathogenic. |
Labcorp Genetics |
RCV000593271 | SCV004677677 | pathogenic | not provided | 2023-10-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln1188*) in the DOCK6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DOCK6 are known to be pathogenic (PMID: 21820096, 25824905). This variant is present in population databases (rs372751467, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with DOCK6-related conditions. ClinVar contains an entry for this variant (Variation ID: 499360). For these reasons, this variant has been classified as Pathogenic. |